Genetic testing has outlined that ~15% of PD cases are Mendelian, with pathogenic/likely pathogenic variants in GBA1 (~10%), LRRK2 (~3%), PRKN (~1%), and other PD genes (~1%).4, 5. This evidence concerns the gene LRRK2 and Parkinson disease.